Group 1 - Guangdian Electric's wholly-owned subsidiary plans to sell 5.91% stake in Shanghai Winshun Electric Technology Co., Ltd. to Yapp Automotive Parts Co., Ltd. for 62.63 million yuan, aiming to optimize asset structure [1] - Anhui Natural Gas received approval for the registration of 500 million yuan short-term financing bonds and 600 million yuan medium-term notes, valid for two years [1] - Kirin Security received government subsidies totaling 6.48 million yuan, which are related to revenue [2] Group 2 - Junshi Biosciences received approval for two new indications for its self-developed drug, Oncorhynchus monoclonal antibody injection, targeting adult patients with heterozygous familial hypercholesterolemia and non-familial hypercholesterolemia [3] - China Resources Double Crane's subsidiary passed GMP compliance inspection for small and large volume injection production lines [4] - Nanjing Public Utilities' board approved the absorption and merger of its wholly-owned subsidiary, Nanjing Jinguang Industry Co., Ltd. [7] Group 3 - Boya Bio received drug registration certificate for human immunoglobulin (pH4) in the Dominican Republic, valid until August 12, 2029 [8] - Jizhi Co. announced that its controlling shareholder and actual controller committed not to reduce their shareholdings until December 31, 2025 [9] - Yuhua Tian won a bid for the integrated urban management project in Lanzhou City, with a total service subsidy of 353 million yuan [10] Group 4 - Anke Rui obtained five invention patent certificates related to various energy management and control technologies [11] - Kebo Da's wholly-owned subsidiary plans to acquire 100% of Czech IMI Company for approximately 9.43 million euros to enhance global production layout [13] - Yantian Port announced a cash dividend of 1.30 yuan per 10 shares, totaling 676 million yuan [14] Group 5 - Huawang Technology plans to distribute a cash dividend of 0.45 yuan per share and a capital reserve increase of 0.20 shares per share [15] - Kabe Yi established a wholly-owned subsidiary in Japan to enhance its business layout [16] - Dongcheng Pharmaceutical's subsidiary received approval for the marketing of sodium fluoride injection, a PET radiopharmaceutical [18] Group 6 - Huaxin New Materials' subsidiary received two utility model patent certificates for innovative devices [19] - Lingang Steel's new 2290 cubic meter blast furnace has been successfully put into operation [21] - Xinlitai received drug registration certificate for Sacubitril/Valsartan tablets, the first of its kind in China [23] Group 7 - Aike Co.'s subsidiary received project designation notices from multiple clients for electric drive platform components [25] - Tonghe Pharmaceutical received drug registration certificate for Apixaban in South Korea [26] - Junting Hotel signed a cooperation agreement with Choice Hotels for exclusive brand usage in mainland China [28] Group 8 - Guangdong Hongtu plans to establish a wholly-owned subsidiary in Zhengzhou to enhance market layout [30] - Yuheng Pharmaceutical signed a joint promotion agreement for Pemafibrate tablets with Xinghe Pharmaceutical [31] - Chongqing Steel terminated the absorption and merger of its wholly-owned subsidiary, citing strategic advantages of independent operation [33] Group 9 - Jihong Co. announced the listing of its H-shares on the Hong Kong Stock Exchange [34] - Deshi Co. announced plans for shareholders to reduce their holdings by up to 0.3% [36] - Xinhai Medical's subsidiary received medical device registration for a dialysis fluid filter [42]

证券代码：300938 证券简称：信测标准 公告编号：2025-102 债券代码：123231 债券简称：信测转债 深圳信测标准技术服务股份有限公司 特别提示： 国平先生计划自本公告披露之日起15个交易日后的未来3个月内（2025年6月18 日至2025年9月17日）以集中竞价或大宗交易方式减持公司股份，合计减持公司 股份不超过300,000股（占公司剔除回购专用账户中股份数量后总股本的0.19%）。 除息的，减持底价下限和股份数将相应进行调整。 深圳信测标准技术服务股份有限公司（以下简称"公司"）于近日收到公司 董事、高级管理人员李国平先生发来的《股份减持计划告知函》，现将有关情况 公告如下： 一、股东的基本情况 姓名 职务 持 股 数 量 占总股 无限售流通 高管锁定股 （股） 本比例 股数（股） 数（股） 李国平 董事、副总经理 1,486,153 0.91% 371,538 1,025,875 二、本次减持计划的主要内容 股东名称 减持原因 股份来源 减持方式 本次拟减持数 占 公 司 总 量上限（股） 股本比例 李国平 个人资金 公 司 首 次 公 开 集 中 竞 价 300,000 0.19% 需 ...

| 证券代码：300938 | 证券简称：信测标准 公告编号：2025-102 | | --- | --- | | 债券代码：123231 | 债券简称：信测转债 | 深圳信测标准技术服务股份有限公司 关于公司部分董事、高级管理人员减持股份的预披露公告 董事、高级管理人员李国平先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 特别提示： 1、持有公司股份1,486,153股（占公司总股本的0.91%）的董事、副总经理李 国平先生计划自本公告披露之日起15个交易日后的未来3个月内（2025年6月18 日至2025年9月17日）以集中竞价或大宗交易方式减持公司股份，合计减持公司 股份不超过300,000股（占公司剔除回购专用账户中股份数量后总股本的0.19%）。 2、以上股东本次拟减持股份数量均不超过其所持有本公司股份总数的25%。 3、如果公司因派发现金红利、送股、转增股本、增发新股等原因进行除权 除息的，减持底价下限和股份数将相应进行调整。 深圳信测标准技术服务股份有限公司（以下简称"公司"）于近日收到 ...

信测标准（300938）公告，持有公司0.91%股份的董事、副总经理李国平计划自2025年6月18日至2025 年9月17日，通过集中竞价或大宗交易方式减持不超过30万股，占剔除回购专用账户中股份数量后总股 本的0.19%。 ...

Group 1 - The company has received approval from the China Securities Regulatory Commission to issue 5,450,000 convertible bonds, with a total issuance amount of 54,500 million yuan, effective from November 29, 2023 [1] - The convertible bonds, named "信测转债" (Xince Convertible Bonds), will be traded on the Shenzhen Stock Exchange starting from November 29, 2023, with a face value of 100 yuan per bond [1] - The conversion period for the bonds is set from May 15, 2024, to November 8, 2029 [1] Group 2 - The company plans to hold its 2024 annual shareholders' meeting on April 21, 2025, to discuss the profit distribution and capital reserve transfer to increase share capital [2] - During the rights distribution period, the convertible bonds will be suspended from conversion if the company has shares in the repurchase account [2] - The bonds will resume conversion on May 29, 2025, after the rights distribution registration date [2]

公司于 2025 年 4 月 21 日召开 2024 年年度股东会，审议通过《关于 2024 年利润分配及资本公积金转增股本的议案》。根据相关规定，公司拟实施利润分 配比例不变的权益分派方法，且公司回购账户存在股份的，实施权益分派期间可 转债暂停转股。公司已于近日发布 2024 年年度权益分派实施公告，根据《深圳 信测标准技术服务股份有限公司创业板向不特定对象发行可转换公司债券募集 说明书》中"转股价格的调整方法及计算公式"条款的规定，公司可转换公司债券 "信测转债"于 2025 年 5 月 21 日至本次权益分派股权登记日（2025 年 5 月 | 证券代码：300938 | 证券简称：信测标准 | 公告编号：2025-101 | | --- | --- | --- | | 债券代码：123231 | 债券简称：信测转债 | | 深圳信测标准技术服务股份有限公司 关于"信测转债"恢复转股的提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 经中国证券监督管理委员会证监许可[2023]1895 号文同意注册，深圳信测标 准技术服务股份有限公 ...

Group 1 - Qingmu Technology plans to reduce its shareholding by up to 3%, amounting to no more than 2.776 million shares [1] - Newcap received a decision from the police to revoke the case against its actual controller, who was previously detained for insider trading [2] - Rhine Biotech's directors and executives plan to collectively reduce their holdings by up to 0.14%, totaling no more than 1.0185 million shares [3] Group 2 - Puli Tui's stock and convertible bonds will be delisted on May 22, 2025 [5] - *ST Nong Shang will have its delisting risk warning lifted and will resume trading on May 23, 2025 [7] - State Grid Information Communication plans to acquire 100% equity of Yili Technology for approximately 1.853 billion yuan [9] Group 3 - Kelun Pharmaceutical's subsidiary received drug registration approval for a new injectable product, which is the first of its kind in China [10] - Aishida plans to acquire 7% equity of its subsidiary Zhejiang Qianjiang Robot Co., Ltd. for 13.09 million yuan [11] - Hongming Co. is planning to acquire 83% equity of Shenzhen Chisu Automation Equipment Co., Ltd. for approximately 151 million yuan [12] Group 4 - JuJiao Co. plans to reduce its shareholding by up to 2.6%, totaling no more than 2.093 million shares [14] - AVIC Financial's stock will be delisted on May 27, 2025 [16] - Jingwang Electronics' major shareholders plan to reduce their holdings by up to 2.99% [17] Group 5 - Huaren Health intends to acquire stakes in three pharmaceutical chain companies for a total of 327 million yuan [18] - Huanrui Century's original shareholders are required to compensate for unfulfilled performance commitments with 116 million shares [20] - Tefa Service's shareholders plan to reduce their holdings by up to 3% [21] Group 6 - Maipu Medical is planning to acquire at least 51% of Easy Medical's equity, which will constitute a major asset restructuring [22] - *ST Jinshi will have its delisting risk warning lifted and its stock will resume trading on May 23, 2025 [22] - Guoke Micro is planning a major asset restructuring and will suspend trading [23] Group 7 - Defu Technology intends to acquire 100% equity of an overseas electronic circuit copper foil company [24] - Xince Standard's shareholder plans to reduce its holdings by up to 1% [25] - Xiouqiang Co. plans to reduce its holdings by up to 3% [27]

证券代码：300938 证券简称：信测标准 公告编号：2025-098 债券代码：123231 债券简称：信测转债 深圳信测标准技术服务股份有限公司 股东青岛信策鑫投资有限公司保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 限公司计划自本公告披露之日起十五个交易日后的三个月内（2025年6月13日至 不超过1,612,200股（占公司剔除回购专用账户中股份数量后总股本的1%）。 除息的，减持底价下限和股份数将相应进行调整。 深圳信测标准技术服务股份有限公司（以下简称"公司"）于近日收到公司 股东青岛信策鑫投资有限公司（以下简称"信策鑫"）发来的《股份减持计划告 知函》，现将有关情况公告如下： 一、股东的基本情况 （一）本次减持计划具体安排 司总股本的1%； 月13日至2025年9月12日，期间如遇到法律法规规定窗口期，则不减持）； 首次公开发行的发行价。如果公司因派发现金红利、送股、转增股本、增发新股 等原因进行除权除息的，减持底价下限和股份数将相应进行调整。 （二）股东的承诺履行情况 截至本公 ...

| 证券代码：300938 | 证券简称：信测标准 公告编号：2025-098 | | --- | --- | | 债券代码：123231 | 债券简称：信测转债 | 深圳信测标准技术服务股份有限公司 关于股东减持股份的预披露公告 股东青岛信策鑫投资有限公司保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 1、持有公司股份5,359,628股（占公司总股本的3.26%）的青岛信策鑫投资有 限公司计划自本公告披露之日起十五个交易日后的三个月内（2025年6月13日至 2025年9月12日）以集中竞价或大宗交易方式减持公司股份，合计减持公司股份 不超过1,612,200股（占公司剔除回购专用账户中股份数量后总股本的1%）。 2、如果公司因派发现金红利、送股、转增股本、增发新股等原因进行除权 除息的，减持底价下限和股份数将相应进行调整。 深圳信测标准技术服务股份有限公司（以下简称"公司"）于近日收到公司 股东青岛信策鑫投资有限公司（以下简称"信策鑫"）发来的《股份减持计划告 知函》，现将有关情况公告如下 ...

信测标准（300938）公告，股东青岛信策鑫投资有限公司计划自公告披露之日起十五个交易日后的三个 月内，通过集中竞价或大宗交易方式减持公司股份不超过161.22万股，占公司总股本的1%。 ...